TMDX ▼ -1.6% - TransMedics Group, Inc. $TMDX TMDX - TransMedics Appoints Fernando Araujo as Chief Financial Officer and Reiterates 2026 Financial Outlook TransMedics appointed Fernando Araujo as Chief Financial Officer and reaffirmed its 2026 financial guidance, but the stock declined 1.6% today. The executive appointment and reiterated outlook had limited impact on investor sentiment at the time of trading. 10-SEP-2026 04:06 PM ET